Date:17/08/2006 URL: http://www.thehindubusinessline.com/2006/08/17/stories/2006081701670300.htm

Back Suven to present pre-clinical data at US forum

Our Bureau

Hyderabad , Aug. 16

Suven Life Sciences Ltd has announced that it would be presenting the pre-clinical data of its promising lead compounds, 5-HT6 antagonists, at the global annual meeting of Neuroscience of the Society for Neuroscience at the Georgia World Congress Centre of Atlanta, US, from October14 to 18.

In a press release here on Wednesday, the company said more than 30,000 scientists from across the world would be attending this year's meet, a premier venue for neuroscientists to share their research findings.

"We are encouraged by the results of these pre-clinical studies which lead us to believe that these selected 5HT6 antagonists may provide a novel, safe and effective approach of treating diseases like mild cognitive impairment, Alzheimer's, Schizophrenia, Parkinson's and obesity," the Suven CEO, Mr Venkat Jasti, said.